gabapentin
Generic: gabapentin
Labeler: aci healthcare usa, inc.Drug Facts
Product Profile
Brand Name
gabapentin
Generic Name
gabapentin
Labeler
aci healthcare usa, inc.
Dosage Form
CAPSULE
Routes
Active Ingredients
gabapentin 300 mg/1
Manufacturer
Identifiers & Regulatory
Product NDC
71093-121
Product ID
71093-121_a916797c-381c-4008-b778-19221233ef45
Product Type
HUMAN PRESCRIPTION DRUG
Marketing Category
ANDA
Application Number
ANDA206943
Listing Expiration
2026-12-31
Marketing Start
2018-05-14
Pharmacologic Class
Physiologic Effect
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
71093121
Hyphenated Format
71093-121
Supplemental Identifiers
RxCUI
UPC
UNII
NUI
Packaging Origin
Original Packager
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
gabapentin (source: ndc)
Generic Name
gabapentin (source: ndc)
Application Number
ANDA206943 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 300 mg/1
Packaging
- 100 CAPSULE in 1 BOTTLE, PLASTIC (71093-121-04)
- 500 CAPSULE in 1 BOTTLE, PLASTIC (71093-121-05)
Packages (2)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "a916797c-381c-4008-b778-19221233ef45", "openfda": {"nui": ["N0000008486"], "upc": ["0371093122048", "0371093120051"], "unii": ["6CW7F3G59X"], "rxcui": ["310430", "310431", "310432"], "spl_set_id": ["7538e255-95df-4991-aae0-a90d709f1e95"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "manufacturer_name": ["ACI Healthcare USA, Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE, PLASTIC (71093-121-04)", "package_ndc": "71093-121-04", "marketing_start_date": "20180804"}, {"sample": false, "description": "500 CAPSULE in 1 BOTTLE, PLASTIC (71093-121-05)", "package_ndc": "71093-121-05", "marketing_start_date": "20180804"}], "brand_name": "Gabapentin", "product_id": "71093-121_a916797c-381c-4008-b778-19221233ef45", "dosage_form": "CAPSULE", "pharm_class": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "product_ndc": "71093-121", "generic_name": "Gabapentin", "labeler_name": "ACI Healthcare USA, Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Gabapentin", "active_ingredients": [{"name": "GABAPENTIN", "strength": "300 mg/1"}], "application_number": "ANDA206943", "marketing_category": "ANDA", "marketing_start_date": "20180514", "listing_expiration_date": "20261231"}